HYDERABAD, India & HARLOW, England--(BUSINESS WIRE)--Feb. 2, 2006--Dr. Reddy’s Laboratories (NYSE: RDY) and Argenta Discovery Limited announced today that they have entered into an agreement for the joint development and commercialization of a novel approach to the treatment of Chronic Obstructive Pulmonary Disease (“COPD”).
